[T-614 for therapy of rheumatoid arthritis].
Hara
Masako
M
Institute of Rheumatology, Tokyo Women's Medical University.
D000818:Animals; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000209:etiology; D001578:Benzopyrans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors; D016207:Cytokines / Q000096:biosynthesis; D003864:Depression, Chemical; D004195:Disease Models, Animal; D006801:Humans; D007136:Immunoglobulins / Q000096:biosynthesis; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D018501:Antirheumatic Agents; D001578:Benzopyrans; D016861:Cyclooxygenase Inhibitors; D016207:Cytokines; D007136:Immunoglobulins; D013449:Sulfonamides; C077313:T 614